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1. Introduction 
Bacitracin, a cyclic polypeptide antibiotic produced 
by Bacillus lichen?for&s, &a variety of inhibitory 
effects in bacterial and animal cells. It blocks the bio- 
synthesis of cell-wall peptidoglycan by preventing the 
dephosphorylation of undecaprenyl pyrophosphate, 
thereby limiting the availability of undecaprenyl 
phosphate, which is essential for muramic acid penta- 
peptide incorporation into the cell wall [2]. This inhi- 
bition is due to the formation of a complex between 
bacitracin, divalent cation and undecaprenyl pyro- 
phosphate [3] . Bacitracin also inhibits the biosyn- 
thesis of squalene and sterols from mevalonate [4] 
and prevents the formation of ubiquinones [5] by a 
similar mechanism. Under some conditions, bacitracin 
induces permeability changes in protoplasts that result 
from its interaction with undecaprenyl pyrophosphate 
molecules in the membrane [6]. More recently, it has 
been shown to inhibit the growth of Halobacterium 
salinarium, a bacterium which contains a glycoprotein 
as one of its major cell-wall components [7]. 
We have shown [ 1,9- 1 l] that calf-pancreas micro- 
somes catalyze the following reactions which are impor- 
tant in the biosynthesis of glycoproteins (for review 
see [S]): 
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Dal-P + UDP-GlcNAc + Dol-PP-GlcNAc + UMP 
Dol-PP-GlcNAc + UDP-GlcNAc + Do~-PP-(G~cNAc)~ 
+ UDP 
Dol-P + GDP-Man -+ Dol-P-Man + GDP 
Dol-P t UDP-Glc + Dol-P-Glc t UDP. 
In the present report, we demonstrate that baci- 
tracin inhibits the formation of Dol-PP-GlcNAc, but 
has relatively little effect on the synthesis of Dol-PP- 
(G~cNAc)~, Dol-P-Man, and Dol-P-Glc. 
2. Materials and methods 
2.1. Materials 
The source of chemicals is described in preceding 
publications [ 1,121. GDP-D- [U-14C]mannose (220-246 
mCi/mmol) and UDP-D [U-14C]glucose (139 mCi/mmol) 
were obtained from New England Nuclear, Boston, MA, 
and UDP-N-acetyl-D-[U-14C]glucosamine (300 mCi/ 
mmol) from Amersham/Searle Corp., Arlington Heights, 
IL. Bacitracin was a product of either Sigma Chemical 
Co., St Louis, MO or the Upjohn Co., Kalamazoo, MI. 
2.2. Preparation of microsomes 
Calf pancreas microsomes were prepared by method 
2 as described previously [I]. 
2.3. Enzyme assays 
The biosynthesis of Dol-P-Man, Dol-P-Glc, and 
Dol-PP-GlcNAc was measured as described previously 
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[ 1 ,l 1 ,121. Microsomes were incubated for 30 min at 
30°C in total vol. 0.5 ml containing 5-6 mg protein/ml, 
Tris-maleate buffer (40 mM), MnClz (10 mM), 2-mer- 
captoethanol (10 mM) and either GDP-D-[U-‘4C] 
mannose, UDP-D- [U-14C]glucose, or UDP-N-acetyl-D 
[U-r4C]glucosamine at a.concentration of 0.05 @/ml. 
The pH of the buffer varied with the nucleotide sugar pre- 
cursor and with the experiment. In experiments with 
exogenous dolichyl phosphate, the appropriate amount 
of dolichyl phosphate solution in chloroform-methanol 
(2: 1) was first added to the tubes, the solvent was eva- 
porated under Nz, and the other constituents were added 
as just described, including Triton X-100 at a final 
concentration of 0.1%. For the biosynthesis of Dol-PP- 
(GlcNAc)*, the medium contained synthetic Dol-PP- 
GlcNAc (20 pg/ml), sodium taurocholate (OS%), Tris- 
maleate buffer, pH 7.3 (40 mM) and UDP-N-acetyl-D- 
[U-‘4C]glucosamine (0.1 &i/ml) in total vol. 0.25 ml. 
At the end of the incubation, the tubes were cooled 
to 4°C and 5 vol. chloroform-methanol (2: 1, v/v) were 
added. The suspension was mixed with a Vortex mixer, 
kept at room temperature for lo-20 min, mixed 
again and centrifuged. The lower chloroform-methanol 
extract was removed with a Pasteur pipette and its 
radioactivity was determined by counting an aliquot 
in 8 ml Aquasol (New England Nuclear, Boston, MA) 
with a Packard liquid scintillation counter model 3375. 
The results presented are averages of duplicate 
incubations. 
3. Results and discussion 
Bacitracin greatly inhibited the incorporation of 
radioactivity from UDP-N-acetyl-D- [ 14C]glucosamine 
into the chloroform-methanol extract (fig.1). Under 
these conditions of incubation, 8085% of the radio- 
activity was recovered in Dol-PP-GlcNAc and the rest 
in Dol-PP-(GIcNAc)~ when the chloroform-methanol 
extract was subjected to thin-layer chromatography on 
silica gel G in chloroform-methanol-water (60:35:6, 
by vol.). Bacitracin inhibited the labeling of both glyco- 
lipids to the same extent. However, when the formation 
of Dol-PP-(GlcNAc)? from synthetic Dol-PP-GlcNAc 
and UDP-N-acetyl-D-[r4C]glucosamine was measured, 
it was found that bacitracin (1 mM) decreased its 
formation by only about 10%. These results show 
that bacitracin inhibits the synthesis of Dol-PP-GlcNAc 
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Fig.1. Effect of bacitracin on the formation of dolichol deriv- 
atives. The conditions of the experiments are described in 
Materials and methods. Incubation with: (o ----•)UDP-N- 
acetyl-D-[U-‘4C]glucosamine, at pH 7.3; (A- ----a)GDP-D- 
[U-‘4C]mannose, at pH 6.3; (o--- o)UDP-D-( U-14C]glucose, 
at pH 5.3. The results are expressed as % radioactivity in the 
absence of bacitracin. These values were 2160 cpm, 13 400 
cpm and 3300 cpm, respectively for dolichol derivatives of 
Nacetylglucosamine, mannose and glucose. 
and has little effect on the formation of Dol-PP- 
(G~cNAc)~ from Dol-PP-GlcNAc. This inhibition was 
concentration dependent and observed with bacitracin 
obtained from two different sources. In contrast, 
bacitracin did not inhibit the formation of Dol-P-Man 
and Dol-P-Glc, the glycolipids found in the chloroform- 
methanol extract after incubation with GDP- [ “Cjman-, 
nose and UDP- [ 14C]glucose respectively (fig.1). In 
fact, some stimulation of Dol-P-Glc and of Dol-P-Man 
synthesis was observed. It is of interest to note that 
Sentandreu et al. [ 131 also reported that bacitracin 
enhanced Dol-P-Man synthesis in yeast. 
It has been shown that the formation of a complex 
between bacitracin, cation, and Cssisoprenyl pyro- 
phosphate is pH dependent with an optimum pH 
between 7.0 and 7.5 [ 141. Since the reactions described 
in fig.1 were performed at the optimum pH for 
each enzyme assay, it was important to determine 
whether the differences observed were related to the 
pH of the incubation. When the experiments were 
repeated with all incubations performed at pH 7 at the 
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Table 1 
Effect of bacitracin on Dol-PP-GlcNAc synthesis in the 
presence and absence of exogenous dolichyl phosphate 
Bacitracin Radioactivity in chloroform-methanol 
(mM) extract (cpm) 
Without Dol-P With Dol-P 
0 1070 1190a 
0.5 560 840a 
1.0 470 690a 
0 2050 2950b 
1.0 1270 1970b 
aDol-P concentration: 40 pg/ml 
bDol-P concentration: 160 pg/ml 
Incubation was performed at pH 7.3 with UDP-N-acetyl-D- 
(“Clglucosamine as described under Materials and methods 
same cation concentration, the results were similar in 
that bacitracin inhibited the formation of Dol-PP- 
GlcNAc without affecting that of Dol-P-Man and 
Dol-P-Glc. 
If the inhibitory action of bacitracin were due to 
complex formation with dolichyl pyrophosphate, 
thereby decreasing the availability of dolichyl phos- 
phate, it should be possible to reverse the effect by the 
addition of exogenous dolichyl phosphate. It was 
found, however, that the inhibitory action of baci- 
tracin on Dol-PP-GlcNAc synthesis was still very 
significant in the presence of a relatively large concen- 
tration of exogenous dolichyl phosphate (table 1). 
These results suggest hat bacitracin has an effect on 
the enzyme involved in Dol-PP-GlcNAc biosynthesis 
rather than an indirect effect due to depletion of lipid 
substrate, such as that observed in bacterial cell-wall 
biosynthesis [3]. The effect of bacitracin may be due 
to membrane disruption [ 151 or may be a direct effect 
on the enzyme in pancreas microsomes. Chen and 
Lennarz [ 161 found that, in hen oviduct membranes, 
incubation with UDP-N-acetyl-D [ 14C]glucosamine in
the presence of bacitracin resulted in the accumulation 
of labeled N-acetylghrcosamine-containing lipids, but 
the mechanism of this effect was not clarified. It is 
not known whether bacitracin interferes with glyco- 
protein biosynthesis in intact cells at the concentra- 
tions used in the present experiments, but it seems pos- 
sible that the inhibitory action of bacitracin reported 
here is related to the toxicity of this drug in vivo 
[ 171 since the formation of Dol-PP-GlcNac is an impor- 
tant step in the biosynthesis of glycoproteins containing 
an N-glycosylic linkage between asparagine and 
N-acetylglucosamine [ 81. 
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